Key result
Splicing regulatory elements within tat exon 2 that control alternative splicing are characteristic of group M HIV-1 strains but are absent in highly divergent group O strains.
Population
HeLa cells and in vitro splicing assays using HIV-1 strains (NL4-3, SF2, ANT70C)
Comparison
Mutagenesis of splicing regulatory elements in… vs Wild-type HIV-1 strains (NL4-3, SF2, ANT70C)
Design
Preclinical
Authors
Loading...
Group M-specific splicing elements may enable selective targeting; leaves open therapeutic relevance pending human validation.
Splicing regulatory elements in tat exon 2 are conserved in group M but not group O HIV-1 strains, highlighting divergent splicing regulation mechanisms among HIV-1 groups.
Bilodeau et al. (1999) studied HIV-1. HIV-1 tat exon 2 sequence variations (Group O vs Group M) vs. Wild-type NL4-3 strain (Group M) was evaluated on Alternative splicing efficiency at tat, rev, and env/nef 3' splice sites. Splicing regulatory elements within tat exon 2 that control alternative splicing are characteristic of group M HIV-1 strains but are absent in highly divergent group O strains.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: